TSE:4502
TSE:4502Pharmaceuticals

Takeda Pharmaceutical (TSE:4502): Reassessing Valuation After Positive 52-Week Rusfertide Phase 3 Data

Takeda Pharmaceutical (TSE:4502) is back in focus after presenting new 52 week Phase 3 VERIFY data for rusfertide in polycythemia vera at the American Society of Hematology meeting, underscoring durable efficacy and a consistent safety profile. See our latest analysis for Takeda Pharmaceutical. The latest rusfertide update lands against a backdrop of steady gains, with Takeda Pharmaceutical’s share price up over the year and a solid multi year total shareholder return suggesting gradually...
TSE:9531
TSE:9531Gas Utilities

Tokyo Gas (TSE:9531) Valuation Check as It Commits Major Capital to US Gas Infrastructure Expansion

Tokyo GasLtd (TSE:9531) just signaled a bigger push into the US, earmarking hundreds of billions of yen for downstream assets such as liquefaction plants and export terminals to tighten its global gas supply chain. See our latest analysis for Tokyo GasLtd. That planned US expansion comes on the back of a powerful rally, with Tokyo GasLtd’s share price up around 42 percent year to date and a hefty 1 year total shareholder return near 44 percent, signaling still strong momentum despite today’s...